Working… Menu

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Retroperitoneal Sarcomas (TORNADO) (TORNADO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04968106
Recruitment Status : Not yet recruiting
First Posted : July 20, 2021
Last Update Posted : December 7, 2021
Incyte Biosciences International Sàrl
Information provided by (Responsible Party):
Institut Bergonié

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : September 2024